NYSE$TMO
Thermo Fisher Scientific Inc · Q2 2023 earnings
Q2 2023 earnings · · Investor relations
Briefing
Thermo Fisher's second quarter results were reported, showing a revenue decrease but strategic advancements.
Thermo Fisher Scientific reported a 3% decrease in revenue to $10.69 billion compared to the same quarter last year, with core organic revenue growth of 2%. GAAP diluted EPS was $3.51, and adjusted EPS was $5.15. The company revised its full-year guidance due to a challenging macroeconomic environment.
- Revenue declined by 3% to $10.69 billion, with a 2% core organic revenue growth.
- GAAP diluted EPS was reported at $3.51, while adjusted EPS reached $5.15.
- The company launched innovative products, including the Thermo Scientific™ Orbitrap™ Astral™ mass spectrometer.
- Thermo Fisher announced an agreement to acquire CorEvitas for approximately $0.9 billion, enhancing its clinical research business.
Headline financials
Revenue & EPS history
Thermo Fisher · Revenue · Quarterly
$10.7B
Revenue by segment
Thermo Fisher · $11.2B total across 4 segments · Q2 2023
- Lab Products & Biopharma$5.83B+5.3%52.3%
- Life Sciences Solutions$2.46B-25.2%22.1%
- Analytical Instruments$1.75B+8.8%15.7%
- Specialty Diagnostics$1.11B+0.7%9.9%
Forward guidance
Thermo Fisher revised its full-year revenue and adjusted EPS guidance due to the macroeconomic environment. The company now expects 2023 revenue to be in the range of $43.4 to $44.0 billion, with core organic revenue growth of 2 to 4%, and adjusted EPS of $22.28 to $22.72.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2023
+0.5%
Avg return
Earnings day
+0.4%
Avg return
5 days after
-0.1%
Avg return
30 days after
53%
39 / 73 earnings
Positive
+9.9%
Q2 2012
Best reaction
-7.8%
Q2 2011
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -0.6% | -8.5% | -12.7% | |
| Q4 2025 | -4.6% | -6.2% | -14.3% | |
| Q3 2025 | +1.5% | +1.0% | +5.3% | |
| Q2 2025 | +3.2% | +5.8% | +6.3% | |
| Q1 2025 | -0.7% | -3.1% | -9.4% | |
| Q4 2024 | +6.8% | +2.2% | -6.9% | |
| Q3 2024 | -4.9% | -5.8% | -12.5% | |
| Q2 2024 | +7.7% | +9.4% | +9.8% | |
| Q1 2024 | -0.5% | +0.4% | +1.6% | |
| Q4 2023 | -2.6% | -2.7% | +1.6% | |
| Q3 2023 | -3.9% | -5.3% | +7.1% | |
| Q2 2023 | -1.9% | -3.9% | -5.1% | |
| Q1 2023 | -1.0% | +0.0% | -4.8% | |
| Q4 2022 | +2.9% | +1.0% | -1.9% | |
| Q3 2022 | -3.2% | -0.1% | +7.1% | |
| Q2 2022 | +2.8% | +0.7% | -3.1% | |
| Q1 2022 | +6.2% | +5.0% | +10.0% | |
| Q4 2021 | +0.1% | -1.2% | -7.9% | |
| Q3 2021 | +1.9% | +4.4% | +5.0% | |
| Q2 2021 | +0.7% | +0.6% | +3.4% | |
| Q1 2021 | -3.2% | -4.2% | -3.4% | |
| Q4 2020 | +1.7% | -3.4% | -11.5% | |
| Q3 2020 | +3.6% | +3.7% | -3.1% | |
| Q2 2020 | +1.8% | +2.6% | +6.3% | |
| Q1 2020 | +0.3% | +7.2% | +6.5% | |
| Q4 2019 | -6.2% | -2.4% | -12.9% | |
| Q3 2019 | +4.4% | +6.7% | +9.5% | |
| Q2 2019 | -1.0% | -1.6% | -8.3% | |
| Q1 2019 | +2.1% | +3.3% | +3.0% | |
| Q4 2018 | +3.7% | +2.8% | +11.5% | |
| Q3 2018 | +3.1% | +2.2% | +5.2% | |
| Q2 2018 | +5.7% | +4.2% | +6.0% | |
| Q1 2018 | +0.3% | -1.3% | +0.2% | |
| Q4 2017 | +3.6% | -2.9% | -3.8% | |
| Q3 2017 | +3.1% | -1.2% | -0.4% | |
| Q2 2017 | -2.7% | -2.6% | -1.6% | |
| Q1 2017 | +5.0% | +4.9% | +9.2% | |
| Q4 2016 | +6.7% | +5.7% | +11.1% | |
| Q3 2016 | -0.6% | -1.4% | -2.6% | |
| Q2 2016 | -0.0% | -1.5% | -4.1% | |
| Q1 2016 | -2.0% | — | — | |
| Q4 2015 | -2.8% | — | — | |
| Q3 2015 | -3.6% | — | — | |
| Q2 2015 | +3.0% | — | — | |
| Q1 2015 | -3.6% | — | — | |
| Q4 2014 | +0.7% | — | — | |
| Q3 2014 | -1.7% | — | — | |
| Q2 2014 | +2.0% | — | — | |
| Q1 2014 | -4.1% | — | — | |
| Q4 2013 | +3.0% | — | — | |
| Q3 2013 | +1.3% | — | — | |
| Q2 2013 | +1.9% | — | — | |
| Q1 2013 | -0.6% | — | — | |
| Q4 2012 | +6.2% | — | — | |
| Q3 2012 | +7.1% | — | — | |
| Q2 2012 | +9.9% | — | — | |
| Q1 2012 | +4.1% | — | — | |
| Q4 2011 | -0.1% | — | — | |
| Q4 2010 | -0.1% | — | — | |
| Q3 2011 | -1.5% | — | — | |
| Q2 2011 | -7.8% | — | — | |
| Q1 2011 | -0.2% | — | — | |
| Q3 2010 | -1.7% | — | — | |
| Q2 2010 | +1.0% | — | — | |
| Q1 2009 | -6.2% | — | — | |
| Q1 2010 | +0.2% | — | — | |
| Q4 2007 | -1.3% | — | — | |
| Q4 2009 | -1.3% | — | — | |
| Q3 2008 | -2.8% | — | — | |
| Q3 2009 | -2.8% | — | — | |
| Q2 2008 | +0.5% | — | — | |
| Q2 2009 | +0.5% | — | — | |
| Q4 2008 | +0.5% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro